What's new

2000 Doctors say Bernie Sanders has the right approach to health care

  • Thread starter Thread starter Deleted member 848
  • Start date Start date
D

Deleted member 848

Guest
More than 2,000 physicians announced their support Thursday for a single-payer national health care system, unveiling a proposal drafted by doctors that appears to resonate with Bernie Sanders' call for "Medicare for All."

In an editorial and paper published in the American Journal of Public Health on Thursday, the doctors call out the "persistent shortcomings of the current health care system." They warn about the risks of continuing along the path laid out by the Affordable Care Act: "down this road, millions of Americans remain uninsured, underinsurance grows, costs rise, and inefficiency and the search for profits are abetted."

The future of health reform has been widely discussed in the presidential campaign, and for years health reform has sparked a raging and divisive political debate among politicians. The proposal, however, is endorsed by hundreds of physicians who have an inside view of the effects of the law on patients and medical care. It grew out of discussions in late 2014, when a small group of physicians began to assess the effects of health reform and found it coming up short.

"Those discussions led us to feel that we needed to put out in public, first of all, a clear statement that problems haven’t been solved," said David Himmelstein, an internist who practices in the South Bronx and a professor at the City University of New York School of Public Health at Hunter College.

Himmelstein and his colleagues call the right to medical care "a dream deferred," despite health reform.

About 12.7 million people are insured through the state and federal marketplaces created by the law, according to data released in February. But the Congressional Budget Office has estimated that about 28 million people will be uninsured in 2026.

On top of that, Himmelstein said he began to notice insured patients having more trouble paying for and accessing care, as their plans have been designed with narrower networks of physicians and growing deductibles -- issues that Himmelstein argues are ripple effects of the law. That's because the insurance policies sold through the marketplaces cover less than traditional employer plans did previously, "and we're seeing employers race to the bottom, once the Affordable Care Act says that's what coverage consists of," Himmelstein said.

Jeffrey Flier, the dean of Harvard Medical School, said the proposal is "massively backward," adding that the one thing it points out correctly is that health reform has been unable to deliver on its promise of affordable health care.


"I don't think it's a very meaningful contribution," Flier said. "It conjures up five-year planning by Stalinists."

The new single-payer proposal doesn't get into many specifics of how it would be funded, other than to estimate that the increase in government health care spending would be balanced by shrinking administrative costs and reductions in the cost of health care services and drugs. The doctors argue that a progressive tax, aimed at reducing income inequality would be an attractive way to fund the system.

"Frankly, there's so much fat in the U.S. health care system -- we're wasting so much money -- that we can afford to give everyone in this country everything that we know is useful without restriction," Himmelstein said.

Kenneth Thorpe, a professor of health policy at Emory University who has been critical of the feasibility and expense of Sanders' single-payer plan, said that the new proposal would cost more than the status quo. It overestimates the administrative savings that would be possible from a single-payer system, Thorpe argues.

"You can’t do what they’re talking about doing with the same amount of money that we’re currently spending," Thorpe said.

He said in addition to a switch to single-payer being disruptive, it's likely to be politically unpalatable. Thorpe's analysis has found that 71 percent of people with private insurance would pay more in a single-payer system than they currently do because taxes would outpace savings from premiums and other health care costs.

However, he noted that many of the ideas embedded in the proposal -- such as new payment models -- are already being experimented with today, under the current system.

Himmelstein said that today, hospitals must collect their operating budget "Band-Aid by Band-Aid and aspirin tablet by aspirin tablet, fighting with hundreds of different insurance plans." The physicians propose funding hospitals with a lump sum to cover all operating expenses, bypassing the large billing departments that today accrue hospital income piecemeal. But Thorpe pointed out similar ideas are already being tested in Maryland hospitals.

"We don’t need to completely blow the system up and disrupt it to generate the savings," Thorpe said.

https://www.washingtonpost.com/news...anders-has-the-right-approach-to-health-care/
 
Here's a comprehensive article from a European academic that offers an opposing view.

https://www.forbes.com/sites/matthe...s-drugs-are-expensive-of-which-two-are-false/

A European academic who spent 12 years working in financial markets, consulting firms, and was involved in drug industry investment

https://www.innogen.ac.uk/people/124

edit: i'm not saying it invalidates his opinion-- it's just important to assert that there's a lot more than simply appraising one as "an academic".
 
oh God, I finished page 1 and realized there's 8 more. I'll have to keep reading it later.

I finished the first reason (where he said it's foolish for pharmaceutical groups to expect to recuperate their costs of R&D) and I think I agree there. If I'm not mistaken, the point he's making is long as your company still runs profits and is able to exist you shouldn't be overly concerned with recovering every dollar lost on R&D-- bringing up Alzheimer's as the example.
 
oh God, I finished page 1 and realized there's 8 more. I'll have to keep reading it later.

It's a very good article. He claims that a single-payer system in the US would seriously slow down medical advances, and he proposes a national/global fund to support difficult and expensive research to off-set that.

I am very interested in having universal healthcare in the US, but I would like to think of ways to minimize its downsides.
 
It's a very good article. He claims that a single-payer system in the US would seriously slow down medical advances, and he proposes a national/global fund to support difficult and expensive research to off-set that.

I am very interested in having universal healthcare in the US, but I would like to think of ways to minimize its downsides.

it's hard for me to take seriously the cries of the pharmaceutical industry when I see how much they spending on marketing relative to R&D, especially in light of the fact that only 2 nations in the world (US, NZ) allow direct-to-consumer advertising between pharmaceutical industries and consumers.
 
it's hard for me to take seriously the cries of the pharmaceutical industry when I see how much they spending on marketing relative to R&D, especially in light of the fact that only 2 nations in the world (US, NZ) allow direct-to-consumer advertising between pharmaceutical industries and consumers.

I agree that serious limitations should be put on that. Nonetheless, Scannell paints an empirical picture of how things stand at the moment, and the downsides of the current system (and they are significant) versus that of switching to a single-payer system.

Like you said, it is a very long article, and I don't have time to summarize the points. But I think it is a more compelling starting point than the usual "morality versus greed" axiom that the argument typically pivots around on these forums.
 
also, having done a degree in Genetics and having worked in biomedical research for three years [aside: I worked on optimizing a protocol for an improvement on DOXIL® by inserting two proteins into the liposomal bilayer: p14 (a protein taken from viruses used to fuse liposomes with a cell's membrane while avoiding its endocytic pathway) and bombesin, a ligand for a receptor over-expressed in many prostate cancer cells] I feel that if we look at various health epidemics, investing cost in public health measures will give us much larger dividends and payouts in the long run than life-saving treatments that inherently evade generalizability.


tl;dr yes, we will zap money away from R&D, which hurts us when working with cystic fibrosis, huntington's disease, or other illnesses tethered to genetics where lifestyle doesn't have a strong pertinence. In contrast, environmental factors impact health on a massive, massive scale, and the per-dollar payout is much more formidable in my opinion.
 
/Muslim thread

2000 doctors?

#1 - doctors are notoriously bad businessman (a joke amongst investment bankers, actually)
#2 - 2000??
 
For all posterity...

I respect the hell outta Dal and his family.
When I disagree it only means he's imperfect.. Nothing more.
 
So having said that... the only perfection I've obtained is perfect imperfection.

I would never want to be someone's 'mark'... Not that anyone here doesn't already know that...lol
 
This reminds me of the time when 2 gazillion economists signed on to a well intended, yet detrimental op-ed begging the Fed to raise interest rates at least 5 years prematurely. "But, but, but they have PhD's" is not the best argument.
 
This reminds me of the time when 2 gazillion economists signed on to a well intended, yet detrimental op-ed begging the Fed to raise interest rates at least 5 years prematurely. "But, but, but they have PhD's" is not the best argument.

I haven't read up on the issue at hand, but I thought I'd chime in to say I genuinely love this appropriately cynical remark from *franklin.
 
Back
Top